Medtronic: Heart Diseases trials

The registry lists 28 Heart Diseases studies with Medtronic as lead sponsor. 4 are open to participants now and 8 have results posted.

Phase 3 2Phase 4 4No phase 22(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)RecruitingNCT07585968Not applicable
• Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)RecruitingNCT06703489Not applicable
• ELEVATE-HFpEF Clinical StudyRecruitingNCT06678841Not applicable
• Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.RecruitingNCT03242642Not applicable
• ADVANCE Direct Aortic StudyCompletedNCT01676727Results posted
• CoreValve Advance-II Study: Prospective International Post-market StudyCompletedNCT01624870Results posted
• Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant TachycardiaCompletedNCT01426425Phase 3Results posted
• Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts IIICompletedNCT00617175Phase 4Results posted
• Randomized Study Comparing Endeavor With Cypher Stents (PROTECT)CompletedNCT00476957Phase 4Results posted
• FAST (Fluid Accumulation Status Trial)CompletedNCT00289276Not applicableResults posted
• Managed Ventricular Pacing ("MVP") TrialTerminatedNCT00281099Not applicableResults posted
• Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)CompletedNCT00267098Not applicableResults posted
• TYRX™ Pocket Health StudyCompletedNCT05356546
• SelectSecure 3830 Lead ImagingCompletedNCT03941275
• Destination Therapy Post Approval StudyActive, not recruitingNCT03681210
• CT Data Collection StudyCompletedNCT03589664
• The PREVAIL StudyCompletedNCT03260517Not applicable
• China Resolute Integrity 34/38 mm StudyCompletedNCT03118531Not applicable
• Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)CompletedNCT02452736Phase 3
• Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial FibrillationCompletedNCT01803438Phase 4
• Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)CompletedNCT01762124Not applicable
• UMBRELLA - Incidence of Arrhythmias in Spanish Population With a Medtronic Implantable Cardiac Defibrillator (ICD) ImplantTerminatedNCT01561144
• Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas DiseaseTerminatedNCT01539161Phase 4
• RESOLUTE China RCTCompletedNCT01334268Not applicable
• RESOLUTE China Registry:CompletedNCT01243749
• RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in AsiaCompletedNCT01132456Not applicable
• The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery LesionsCompletedNCT00614848Not applicable
• D2-EPG Study: Evaluation of New Sensing Circuitry and Capture ManagementCompletedNCT00328705Not applicable